Numerous preclinical studies have demonstrated that mTOR inhibitors, particularly rapalogs like rapamycin and temsirolimus, can effectively inhibit glioblastoma tumor growth in mouse xenograft and orthotopic models. Here, MTOR is linked to neoplasm.